DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

13F Filings History

Latest 13F report
Q2 2024 - Aug 14, 2024
Value $
$6.01B
Signature - Title
Flynn Management LLC, Its general partner and James E. Flynn - Managing Member
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). Form 13F is required to be filed within 45 days of the end of a calendar quarter. DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) reported 433 stock holdings with total value $6.01B as of Q2 2024. Top holdings included NUVL, VTRS, CNC, MRUS, and LRMR.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2024 433 $6.01B +$1.12B -$578M +$543M NUVL, VTRS, CNC, MRUS, LRMR 13F-HR 8/14/2024, 04:30 PM
Q1 2024 367 $5.75B +$889M -$1.21B -$321M NUVL, VTRS, CNC, LRMR, AHCO 13F-HR 5/15/2024, 04:00 PM
Q4 2023 222 $5.42B +$583M -$688M -$106M NUVL, VTRS, CPRX, CNC, NBIX 13F-HR 2/14/2024, 04:01 PM
Q3 2023 88 $4.54B +$651M -$733M -$81.1M NUVL, VTRS, CNC, NBIX, AHCO 13F-HR 11/14/2023, 04:01 PM
Q2 2023 101 $4.68B +$468M -$720M -$252M NUVL, VTRS, AMED, AHCO, NBIX 13F-HR 8/14/2023, 04:23 PM
Q1 2023 106 $4.49B +$727M -$907M -$179M NUVL, NBIX, CPRX, VTRS, AHCO 13F-HR 5/15/2023, 04:00 PM
Q4 2022 104 $4.83B +$1.03B -$1.35B -$321M NUVL, NBIX, AHCO, VTRS, CPRX 13F-HR 2/14/2023, 04:11 PM
Q3 2022 126 $5.01B +$932M -$1.16B -$225M NUVL, NBIX, AHCO, SILK, CMAX 13F-HR 11/14/2022, 04:27 PM
Q2 2022 123 $4.75B +$1.03B -$307M +$724M NUVL, VTRS, AHCO, NBIX, SILK 13F-HR 8/15/2022, 04:53 PM
Q1 2022 118 $4.44B +$744M -$486M +$258M NUVL, VTRS, AHCO, NBIX, CMAX 13F-HR 5/16/2022, 04:50 PM
Q4 2021 125 $4.75B +$799M -$636M +$163M NUVL, VTRS, AHCO, CMAX, NBIX 13F-HR 2/14/2022, 05:06 PM
Q3 2021 132 $5.11B +$1.09B -$961M +$130M NUVL, VTRS, AHCO, CMAX, NBIX 13F-HR 11/15/2021, 04:53 PM
Q2 2021 143 $5.63B +$2.14B -$1.11B +$1.03B VTRS, OMIC, CMAX, AHCO, ORGO 13F-HR 8/16/2021, 04:27 PM
Q1 2021 133 $4.76B +$2.34B -$2.25B +$83.1M VTRS, EWTX, CNC, BSX, DFPH 13F-HR 5/17/2021, 04:26 PM
Q4 2020 129 $5.06B +$2.59B -$2.25B +$333M VTRS, GRAY, CNC, AFIB, LRMR 13F-HR 2/16/2021, 04:23 PM
Q3 2020 105 $4.11B +$1.68B -$1.26B +$425M MYL, IMMU, HZNP, AFIB, DFPHU Restatement 12/30/2020, 04:23 PM
Q2 2020 93 $3.43B +$872M -$1.47B -$593M MYL, SDGR, DFPHU, HZNP, IMMU 13F-HR 8/14/2020, 04:39 PM
Q1 2020 90 $3.14B +$1.13B -$623M +$507M AHCO, MYL, HZNP, DFPHU, CNC 13F-HR 5/15/2020, 04:13 PM
Q4 2019 75 $3.13B +$691M -$671M +$19.4M AHCO, HZNP, MYL, ORTX, FIXX 13F-HR 2/14/2020, 04:03 PM
Q3 2019 94 $2.45B +$326M -$417M -$90.4M HZNP, MYL, ORTX, FIXX, AERI 13F-HR 11/14/2019, 04:05 PM
Q2 2019 96 $2.78B +$832M -$511M +$321M HZNP, MYL, ORTX, FIXX, AERI 13F-HR 8/14/2019, 04:06 PM
Q1 2019 93 $2.61B +$313M -$544M -$231M HZNP, FIXX, ORTX, PTLA, MYL 13F-HR 5/15/2019, 04:31 PM
Q4 2018 98 $2.46B +$570M -$460M +$110M HZNP, ORTX, FIXX, MYL, VCEL 13F-HR 2/14/2019, 04:05 PM
Q3 2018 102 $2.75B +$634M -$923M -$289M HZNP, FIXX, AERI, MYL, PTLA 13F-HR 11/14/2018, 04:15 PM
Q2 2018 113 $2.81B +$522M -$724M -$202M MNKKQ, HZNP, FIXX, MRTX, MYL 13F-HR 8/14/2018, 04:30 PM
Q1 2018 115 $2.82B +$798M -$540M +$258M MNKKQ, MYL, FIXX, HZNP, AVXS 13F-HR 5/15/2018, 04:31 PM
Q4 2017 97 $2.53B +$654M -$453M +$201M MNKKQ, MYL, HZNP, DXCM, GKOS 13F-HR 2/14/2018, 04:20 PM
Q3 2017 90 $2.21B +$672M -$396M +$276M AVXS, MCK, MYL, HZNP, GKOS 13F-HR 11/13/2017, 11:38 AM
Q2 2017 82 $1.81B +$232M -$1.02B -$787M AVXS, HZNP, NXTM, GILD, MYL 13F-HR 8/14/2017, 04:02 PM
Q1 2017 105 $2.58B +$529M -$689M -$160M AVXS, HZNP, NXTM, GILD, MYL 13F-HR 5/15/2017, 04:03 PM
Q4 2016 101 $2.41B +$647M -$217M +$430M HZNP, NXTM, AVXS, PTLA, GWPH 13F-HR 2/14/2017, 05:03 PM
Q3 2016 90 $2.15B +$232M -$976M -$744M GWPH, PTLA, HZNP, NXTM, AVXS 13F-HR 11/14/2016, 04:29 PM
Q2 2016 106 $2.54B +$500M -$461M +$39.3M HZNP, NXTM, GWPH, PTLA, AVXS 13F-HR 8/15/2016, 10:22 AM
Q1 2016 105 $2.33B +$746M -$405M +$341M HZNP, MYL, NXTM, GSK, AET 13F-HR 5/16/2016, 04:05 PM
Q4 2015 107 $2.38B +$370M -$686M -$316M HZNP, NXTM, DYAX, ADPTQ, GSK 13F-HR 2/16/2016, 04:01 PM
Q3 2015 133 $2.55B +$594M -$435M +$159M HZNP, NXTM, GSK, AET, FLML 13F-HR 11/16/2015, 04:02 PM
Q2 2015 119 $2.99B +$843M -$1.13B -$284M HZNP, FLML, NXTM, ARRY, DYAX 13F-HR 8/14/2015, 04:18 PM
Q1 2015 1 $1.04M $0 $0 New Holdings 8/14/2015, 04:16 PM
Q1 2015 121 $3.06B +$964M -$980M -$16M ASPX, HZNP, ABBV, NXTM, ARRY 13F-HR 5/15/2015, 04:02 PM
Q4 2014 106 $2.68B +$630M -$922M -$293M AUXL, ASPX, HZNP, AGN, FLML 13F-HR 2/17/2015, 04:31 PM
Q3 2014 121 $2.46B +$765M -$481M +$283M AUXL, AGN, NXTM, FLML, AAVL 13F-HR 11/14/2014, 04:33 PM
Q2 2014 117 $2.25B +$680M -$687M -$7.1M AUXL, ITMN, FLML, AGN, NXTM 13F-HR 8/14/2014, 04:33 PM
Q1 2014 115 $2.18B +$832M -$621M +$211M FLML, AUXL, LH, DRNA, QCOR 13F-HR 5/15/2014, 04:31 PM
Q4 2013 98 $1.77B $0 $0 AUXL, QCOR, ARRY, NXTM, INFI 13F-HR 2/14/2014, 04:25 PM